Related Experiment Video
Updated: Jun 20, 2026
Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
Epigenetic DNA hypermethylation: clinical applications in endometrial cancer (Review)
Yuriko Muraki1, Kouji Banno, Megumi Yanokura
1Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Abstract:
Improvements in epigenetics have resulted in identification of a number of genes with aberrant hypermethylation associated with systematic occurrence of cancer. It is now evident that aberrant hypermethylation inactivates cancer-related genes including those associated with cell cycle control, apoptosis, and DNA repair. An epigenetic analysis of DNA hypermethylation in type I endometrial cancer has led to a proposed mechanism for endometrial carcinogenesis. Reduced DNA mismatch repair due to loss of hMLH1 expression is thought to have a major role in carcinogenesis and these findings open up approaches to prevention, diagnosis, risk assessment, and treatment of type I endometrial cancer. Aberrant DNA hypermethylation can be detected with high sensitivity for identification of cancer cells in sputum, blood and other biopsy materials, including in endometrial cancer specimens. There have been many attempts to use methylation inhibitors as anticancer agents, and epigenetic abnormalities may be useful as biomarkers of anticancer drug sensitivity and to identify biological characteristics of tumor cells for determination of treatment options based on hypermethylation. For example, aberrant hypermethylation of the CHFR gene is correlated with cellular sensitivity to microtubule inhibitors, and this may be useful in treatment of type I endometrial cancer. An ultimate objective of epigenetics is to identify the type of hereditary methylation responsible for cancer, with the goal of improved diagnosis and treatment based on control of methylation.
Insights
Epigenetic changes, specifically DNA hypermethylation, are linked to cancer development by inactivating key genes. This research proposes a mechanism for endometrial cancer and highlights hypermethylation
Area of Science:
- Epigenetics
- Molecular Biology
- Oncology
Background:
- Aberrant DNA hypermethylation is increasingly identified in various cancers, inactivating critical genes involved in cell cycle control, apoptosis, and DNA repair.
- Epigenetic alterations play a significant role in the systematic occurrence and progression of cancer.
- Understanding these epigenetic modifications is crucial for developing novel cancer therapies.
Purpose of the Study:
- To propose a mechanism for endometrial carcinogenesis based on epigenetic analysis of DNA hypermethylation.
- To explore the potential of aberrant DNA hypermethylation as a biomarker for cancer detection and treatment selection.
- To investigate the role of reduced DNA mismatch repair due to hMLH1 loss in endometrial cancer.
Main Methods:
- Epigenetic analysis focusing on DNA hypermethylation patterns in endometrial cancer.
- Detection of aberrant DNA hypermethylation in various biological samples including sputum, blood, and biopsy materials.
- Correlation analysis between gene hypermethylation (e.g., CHFR) and sensitivity to specific anticancer agents (e.g., microtubule inhibitors).
Main Results:
- A proposed mechanism for type I endometrial carcinogenesis involving reduced DNA mismatch repair due to hMLH1 loss.
- High sensitivity detection of aberrant DNA hypermethylation for identifying cancer cells in clinical specimens.
- Correlation between CHFR gene hypermethylation and cellular sensitivity to microtubule inhibitors, suggesting potential therapeutic applications.
Conclusions:
- Aberrant DNA hypermethylation is a key factor in endometrial carcinogenesis and can serve as a valuable biomarker.
- Epigenetic abnormalities offer new avenues for cancer prevention, diagnosis, risk assessment, and personalized treatment strategies.
- Targeting epigenetic modifications, such as using methylation inhibitors or exploiting methylation patterns for drug sensitivity, holds promise for improved cancer therapy.
Related Concept Videos
01:37Epigenetic Regulation
X-chromosome...
01:46Epigenetic Regulation
02:30Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...